ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Charité – Universitätsmedizin Berlin at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Charité – Universitätsmedizin Berlin takes part in 12 sessions at ESMO 2026 in Madrid. Its work applies molecular profiling and data analysis to treatment decisions across cancers. It examines how artificial intelligence can help align prostate cancer treatment recommendations with clinical guidelines.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
University hospital and medical faculty shared by Freie Universität Berlin and Humboldt-Universität zu Berlin, in Berlin, Germany.
Poster
Fri Oct 23
13:00–15:00
Variant-level therapy annotation using multi-agent RAG benchmarked against real-world MTB recommendations
ePoster session 2
Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Abstract
Fri Oct 23
13:30–13:40
Poster
Fri Oct 23
15:15–16:00
Systematic evaluation of tumor-agnostic activity in molecularly stratified clinical trials
Friday Poster Display session 3
Biomarkers & precision oncology
Chair
Sat Oct 24
08:30–10:00
Challenges in the treatment approach of HPV-related head and neck cancers
with Princess Margaret Cancer Centre
Sarcoma, CNS, head & neck and rare cancers
Talk
Sat Oct 24
09:30–09:50
Biomarkers to tailor treatment and monitor disease
Challenges in the treatment approach of HPV-related head and neck cancers
Sarcoma, CNS, head & neck and rare cancers
Satellite
Sat Oct 24
13:25–13:45
KRAS G12C in Advanced NSCLC: Progress Made, Gaps Remaining
Eli Lilly and Company - KRAS G12C-Mutant NSCLC Across the Disease Continuum: From Biology and Unmet Needs to Optimizing Care
Lung & thoracic cancers
Talk
Sat Oct 24
15:00–15:15
Small cell neuroendocrine tumours
Rare GU cancers
Genitourinary cancers
Poster
Sun Oct 25
12:00–12:45
Feasibility of AI-based harmonization of multicentric real-world datasets in hepatocellular carcinoma
Sunday Poster Display session 1
Gastrointestinal cancers
Poster
Sun Oct 25
12:00–12:45
Multi-agent vs native LLM pipelines for guideline-compliant prostate cancer therapy: Benchmarking six open-weight models
Sunday Poster Display session 1
Lung & thoracic cancersGenitourinary cancers
Poster
Sun Oct 25
12:00–12:45
Satellite
Sun Oct 25
13:40–13:55
The role of molecular profiling in mCRC
Pierre Fabre Laboratories - BRAFV600E-mutant mCRC: Precision medicine in practice
Gastrointestinal cancersBiomarkers & precision oncology
Satellite
Sun Oct 25
13:55–14:25
From the clinic: Applying precision medicine in practice
Pierre Fabre Laboratories - BRAFV600E-mutant mCRC: Precision medicine in practice · with Vall d'Hebron University Hospital, MD Anderson Cancer Center, Peter MacCallum Cancer Centre
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
EXPRESSION VIII: Final results of the individual level of information and illness perception of patients with low-grade ovarian carcinoma
Monday Poster Display session 1
Gynaecological cancersSarcoma, CNS, head & neck and rare cancersNursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Charité – Universitätsmedizin Berlin

Tell us what you sell and we’ll find the people at Charité – Universitätsmedizin Berlin most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction